Edwards Lifesciences Corporation (EW)

67.06 -1.55  -2.26%  May 17, 8:00PM
Add to Watchlists Create an Alert

Edwards Lifesciences Corporation R&D Expense Quarterly:

79.80M for March 31, 2013
View Full Chart

Edwards Lifesciences Corporation R&D Expense Quarterly Chart

    Edwards Lifesciences Corporation Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 79.80M
    Dec. 31, 2012 74.90M
    Sept. 30, 2012 73.80M
    June 30, 2012 74.00M
    March 31, 2012 68.60M
    Dec. 31, 2011 60.70M
    Sept. 30, 2011 61.70M
    June 30, 2011 64.90M
    March 31, 2011 59.00M
    Dec. 31, 2010 55.90M
    Sept. 30, 2010 52.70M
    June 30, 2010 50.60M
    March 31, 2010 45.20M
    Dec. 31, 2009 48.30M
    Sept. 30, 2009 44.70M
    June 30, 2009 42.60M
    March 31, 2009 39.90M
    Dec. 31, 2008 35.80M
    Sept. 30, 2008 35.10M
    June 30, 2008 35.40M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    EW R&D Expense Quarterly Benchmarks

    Companies
    Stryker Corporation 129.00M
    St Jude Medical 160.00M
    Opko Health 6.578M

    EW R&D Expense Quarterly Rankings

    Overall 98th percentile
    150 of 7590
    Sector 94th percentile
    39 of 651 in Healthcare
    Industry 93rd percentile
    6 of 90 in Medical Devices

    EW R&D Expense Quarterly Range, Past 5 Years

    Minimum 35.10M Sep 2008
    Maximum 79.80M Mar 2013
    Average 55.18M